Adipose Tissue Gene Expression of Factors Related to Lipid Processing in Obesity
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Adipose tissue lipid storage and processing capacity can be a key factor for obesity-related metabolic disorders such as insulin resistance and diabetes. Lipid uptake is the first step to adipose tissue lipid storage. The aim of this study was to analyze the gene expression of factors involved in lipid uptake and processing in subcutaneous (SAT) and visceral (VAT) adipose tissue according to body mass index (BMI) and the degree of insulin resistance (IR). METHODS AND PRINCIPAL FINDINGS: VLDL receptor (VLDLR), lipoprotein lipase (LPL), acylation stimulating protein (ASP), LDL receptor-related protein 1 (LRP1) and fatty acid binding protein 4 (FABP4) gene expression was measured in VAT and SAT from 28 morbidly obese patients with Type 2 Diabetes Mellitus (T2DM) or high IR, 10 morbidly obese patients with low IR, 10 obese patients with low IR and 12 lean healthy controls. LPL, FABP4, LRP1 and ASP expression in VAT was higher in lean controls. In SAT, LPL and FABP4 expression were also higher in lean controls. BMI, plasma insulin levels and HOMA-IR correlated negatively with LPL expression in both VAT and SAT as well as with FABP4 expression in VAT. FABP4 gene expression in SAT correlated inversely with BMI and HOMA-IR. However, multiple regression analysis showed that BMI was the main variable contributing to LPL and FABP4 gene expression in both VAT and SAT. CONCLUSIONS: Morbidly obese patients have a lower gene expression of factors related with lipid uptake and processing in comparison with healthy lean persons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lipolysis of TG-rich lipoproteins is impaired in obesity by reduced mRNA expression levels of LPL in adipose tissue [50], reductions in LPL activity in skeletal muscle and competition for lipolysis between VLDL and chylomicrons [11].”
From Dyslipidemia in obesity: Mechanisms and potential targets (2013) · cites this paper as [50]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recently, it has been described that ASP mRNA expression in visceral adipose tissue is reduced by approximately 40% in obese and morbidly obese subjects with or without insulin resistance when compared to lean controls [50].”
From Dyslipidemia in obesity: Mechanisms and potential targets (2013) · cites this paper as [50]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 1×
“Before surgery and after an overnight fast, blood samples were obtained from the antecubital vein and placed in vacutainer tubes (BD vacutainer™, London, UK). The serum was separated by centrifugation for 10 min at 4000 rpm and immediately frozen at −80°C until analysis. Serum glucose, cholesterol, triglycerides and H…”
InfluentialAdipose tissue expandability, lipotoxicity and the Metabolic Syndrome — An allostatic perspective
Virtue, S., & Vidal-Puig, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.12.006 · Cited by 1,013 · cited 1×
“This suggests that as the BMI increases the lipid storage capacity in adipose tissue could decrease, which could be related with the development of the IR that later appeared in these patients, as proposed by others [37].”
Lipoprotein lipase: from gene to obesity
Wang, H., & Eckel, R. H. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90920.2008 · Cited by 741 · cited 5×
“Glucose also increases adipose tissue LPL activity but, unlike insulin, glucose does not affect the level of LPL mRNA [5,33].”
InfluentialMetabolic and Body Composition Factors in Subgroups of Obesity: What Do We Know?
Karelis, A. D., St-Pierre, D. H., Conus, F., Rabasa-Lhoret, R., & Poehlman, E. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0165 · Cited by 723 · cited 1×
“It has been proposed that the expansion capacity of the adipose tissue rather than the adipose tissue size could be, at least in part, responsible for these inter-individual differences [3], and fat accumulation in the visceral adipose tissue (VAT) is a higher risk factor for the development of clinical complications…”
Mahley, R. W., & Ji, Z.-S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33334-4 · Cited by 693
Unger, R. H. (2003) · Endocrinology · doi:10.1210/en.2003-0870 · Cited by 677 · cited 13×
“More specifically, LRP1 gene expression was significantly higher in SAT than in VAT in the obese (p = 0.018), MO LIR/T2DM (p = 0.007) and MO HIR (p = 0.007) patient groups; LPL gene expression was significantly greater in SAT than in VAT in the obese (p = 0.012) and MO HIR/T2DM (p = 0.002) groups.”
InfluentialMaeda, K., Cao, H., Kono, K., Gorgun, C. Z., Furuhashi, M., Uysal, K. T., Cao, Q., Atsumi, G., Malone, H., Krishnan, B., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.008 · Cited by 477 · cited 2×
“These FABPs direct FFA into the different metabolic pathways [11].”
Kowal, R. C., Herz, J., Weisgraber, K. H., Mahley, R. W., Brown, M. S., & Goldstein, J. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)87014-4 · Cited by 445 · cited 1×
“LRP1 interacts with apoE-enriched chylomicron and VLDL remnants [8] and it is stimulated by insulin in adipocytes,”
Fried, S. K., Russell, C. D., Grauso, N. L., & Brolin, R. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116821 · Cited by 358 · cited 1×
“Insulin increases the levels of LPL mRNA and LPL activity in abdominal SAT but not VAT [34,35].”
Dusserre, E., Moulin, P., & Vidal, H. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00091-5 · Cited by 323 · cited 2×
“We also saw that ASP gene expression was greater in VAT than SAT, in agreement with earlier studies [28,30].”
Fatty Acid Binding Proteins—The Evolutionary Crossroads of Inflammatory and Metabolic Responses
Makowski, L., & Hotamisligil, G. S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.9.2464s · Cited by 311 · cited 1×
“It is one of the most abundant cytoplasmic proteins in mature adipocytes [11] and its function has been associated with insulin sensitivity, lipid metabolism and inflammation [12].”
Frykman, P. K., Brown, M. S., Yamamoto, T., Goldstein, J. L., & Herz, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8453 · Cited by 256 · cited 1×
“Moreover, vldlr (2)/(2) mice experienced a reduction in adipocyte size, suggesting reduced adipocyte triglyceride storage, and their LPL activity was reduced [17,18].”
Semenkovich, C. F., Wims, M., Noe, L., Etienne, J., & Chan, L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81898-1 · Cited by 249 · cited 1×
“Insulin has a major effect on LPL regulation in adipose tissue since in mature adipocytes insulin not only increases the level of LPL mRNA but also regulates LPL activity through both posttranscriptional and posttranslational mechanisms [5,32].”
Hypertrophy and hyperplasia of abdominal adipose tissues in women
Drolet, R., Richard, C., Sniderman, A. D., Mailloux, J., Fortier, M., Huot, C., Rhéaume, C., & Tchernof, A. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803708 · Cited by 243 · cited 1×
“Several studies have shown a higher gene expression of FABP4 in the SAT than in the VAT of obese subjects [21,22].”
Boycott, K. M., Flavelle, S., Bureau, A., Glass, H. C., Fujiwara, T. M., Wirrell, E., Davey, K., Chudley, A. E., Scott, J. N., McLeod, D. R., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/444400 · Cited by 221 · cited 1×
“Concordantly, in humans VLDLR deficiency has been reported and affected patients were also underweight [19].”
High Expression of Complement Components in Omental Adipose Tissue in Obese Men
Gabrielsson, B. G., Johansson, J. M., Lönn, M., Jernås, M., Olbers, T., Peltonen, M., Larsson, I., Lönn, L., Sjöström, L., Carlsson, B., et al. (2003) · Obesity Research · doi:10.1038/oby.2003.100 · Cited by 218 · cited 2×
“We also saw that ASP gene expression was greater in VAT than SAT, in agreement with earlier studies [28,30].”
The obese healthy paradox: is inflammation the answer?
Barbarroja, N., López-Pedrera, R., Mayas, M. D., García-Fuentes, E., Garrido-Sánchez, L., Macías-González, M., El Bekay, R., Vidal-Puig, A., & Tinahones, F. J. (2010) · Biochemical Journal · doi:10.1042/bj20100285 · Cited by 174 · cited 1×
“Obesity is usually related to a number of co-morbidities, such as Type 2 Diabetes Mellitus (T2DM), insulin resistance (IR), cardiovascular disease or dyslipidemia, though there exist metabolically healthy obese patients without these obesity-related complications [1,2].”
Self-citationVan Harmelen, V., Reynisdottir, S., Cianflone, K., Degerman, E., Hoffstedt, J., Nilsell, K., Sniderman, A., & Arner, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18243 · Cited by 167
Hofmann, S. M., Zhou, L., Perez-Tilve, D., Greer, T., Grant, E., Wancata, L., Thomas, A., Pfluger, P. T., Basford, J. E., Gilham, D., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31929 · Cited by 165 · cited 1×
“Murine studies with adipocyte-specific inactivation of the LRP1 gene have shown that LRP1 expression in these cells plays an important role in obesity development since these mice displayed a delayed postprandial lipid clearance and were resistant to diet-induced obesity [10].”
Reaven, G. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.017 · Cited by 135 · cited 2×
“The prevalence of obesity has increased over recent decades and it is now considered a major health problem [1].”
Protection From Obesity in Mice Lacking the VLDL Receptor
Goudriaan, J. R., Tacken, P. J., Dahlmans, V. E. H., Gijbels, M. J. J., van Dijk, K. W., Havekes, L. M., & Jong, M. C. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.095147 · Cited by 133
Acylation stimulating protein (ASP), an adipocyte autocrine: new directions
Cianflone, K., Maslowska, M., & Sniderman, A. D. (1999) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.1998.0272 · Cited by 131 · cited 3×
“ASP is produced in the adipose tissue by the posttranslational cleavage of C3 complement factor [13].”
InfluentialInflammation is associated with a decrease of lipogenic factors in omental fat in women
Poulain-Godefroy, O., Lecoeur, C., Pattou, F., Frühbeck, G., & Froguel, P. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00926.2007 · Cited by 127 · cited 4×
“Differences in mRNA expression levels between the SAT and VAT were analyzed by the Wilcoxon test.”
MethodInfluentialNeville, M. J., Collins, J. M., Gloyn, A. L., McCarthy, M. I., & Karpe, F. (2011) · Obesity · doi:10.1038/oby.2010.257 · Cited by 119 · cited 1×
“3) used as endogenous control for the target gene in each reaction [40], LPL (Hs00173425_m1, RefSeq.”
Voshol, P. J., Rensen, P. C. N., van Dijk, K. W., Romijn, J. A., & Havekes, L. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.12.015 · Cited by 111
Descamps, O., Bilheimer, D., & Herz, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54029-1 · Cited by 103 · cited 1×
“resulting in an increased uptake of triglycerides and cholesteryl ester from remnant lipoproteins [9].”
Yang, Y., Lü, H., Zhang, J., Yu, H. Y., Wang, H. W., Zhang, M., & Cianflone, K. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803173 · Cited by 93 · cited 1×
“However, obesity is not an essential feature of elevated plasma ASP levels, as ASP is increased in subjects with diabetes or polycystic ovary syndrome, even in the absence of obesity [26].”
Koistinen, H. A., Vidal, H., Karonen, S.-L., Dusserre, E., Vallier, P., Koivisto, V. A., & Ebeling, P. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.1034 · Cited by 89 · cited 1×
“found that overweight patients, with and without T2DM, had a higher C3 gene expression than lean healthy controls in the SAT [29].”
MacLaren, R., Cui, W., Lü, H., Simard, S., & Cianflone, K. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-3 · Cited by 87 · cited 1×
“Few studies have examined C3 gene expression in adipose tissue [27– 31].”
ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes
Faraj, M., Sniderman, A. D., & Cianflone, K. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300299-jlr200 · Cited by 87 · cited 1×
“In addition, ASP indirectly increases LPL activity [25].”
Living up to a name: the role of the VLDL receptor in lipid metabolism
Tacken, P. J., Hofker, M. H., Havekes, L. M., & van Dijk, K. W. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00006 · Cited by 83
Fisher, R. M., Eriksson, P. O., Hoffstedt, J., Hotamışlıgil, G. S., Thörne, A., Rydén, M., Hamsten, A., & Arner, P. (2001) · Diabetologia · doi:10.1007/s001250100643 · Cited by 73 · cited 1×
“Several studies have shown a higher gene expression of FABP4 in the SAT than in the VAT of obese subjects [21,22].”
LRP1 Receptor Controls Adipogenesis and Is Up-Regulated In Human and Mouse Obese Adipose Tissue
Masson, O., Chavey, C., Dray, C., Meulle, A., Daviaud, D., Quilliot, D., Muller, C., Valet, P., & Liaudet-Coopman, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007422 · Cited by 70 · cited 1×
“recently reported that LRP1 mRNA expression in human VAT is increased in obese patients with respect to lean controls [15].”
Tinahones, F. J., Garrido‐Sánchez, L., Miranda, M., García‐Almeida, J. M., Macías‐González, M., Ceperuelo‐Mallafré, V., Gluckmann, E., Rivas-Marín, J., Vendrell, J. J., & García‐Fuentes, E. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0194-z · Cited by 60 · cited 1×
“Our group has previously shown that gene expression of FABP4 was lower in morbidly obese persons than in lean persons in SAT [24].”
Self-citationGarcía‐Fuentes, E., Murri, M., Garrido‐Sánchez, L., García‐Serrano, S., García‐Almeida, J. M., Moreno‐Santos, I., Tinahones, F. J., & Macías‐González, M. (2009) · Obesity · doi:10.1038/oby.2009.314 · Cited by 47
Self-citationAcylation-stimulating protein precursor proteins in adipose tissue in human obesity
Xia, Z., & Cianflone, K. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00254-3 · Cited by 34 · cited 1×
“. Few studies have examined C3 gene expression in adipose tissue”
Lipoprotein lipase activity/mass ratio is higher in omental than in subcutaneous adipose tissue
Ruge, T., Sukonina, V., Myrnäs, T., Lundgren, M., Eriksson, J. W., & Olivecrona, G. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01584.x · Cited by 31 · cited 1×
“This could be because the specific LPL activity is greater in VAT than in SAT [36].”
Crawford, D. C., Nord, A. S., Badzioch, M. D., Ranchalis, J., McKinstry, L. A., Ahearn, M., Bertucci, C., Shephard, C., Wong, M., Rieder, M. J., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700409-jlr200 · Cited by 28
Kern, P. A., Mandic, A., & Eckel, R. H. (1987) · Diabetes · doi:10.2337/diab.36.11.1238 · Cited by 24 · cited 1×
“Glucose also increases adipose tissue LPL activity but, unlike insulin, glucose does not affect the level of LPL mRNA [5,33].”
Panarotto, D., Poisson, J., Devroede, G. J., & Maheux, P. (2000) · Metabolism · doi:10.1053/meta.2000.8624 · Cited by 22 · cited 1×
“Insulin increases the levels of LPL mRNA and LPL activity in abdominal SAT but not VAT [34,35].”
Cited by
Jung, U., & Choi, M.-S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046184 · Cited by 1,880
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
“Recently, it has been described that ASP mRNA expression in visceral adipose tissue is reduced by approximately 40% in obese and morbidly obese subjects with or without insulin resistance when compared to lean controls [50].”
BackgroundObesity-Related Changes in High-Density Lipoprotein Metabolism and Function
Stadler, J. T., & Marsche, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238985 · Cited by 200
Adiponectin: A potential therapeutic target for metabolic syndrome
Ghadge, A. A., Khaire, A. A., & Kuvalekar, A. A. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.01.004 · Cited by 185
Does Metabolically Healthy Obesity Exist?
Muñoz-Garach, A., Cornejo-Pareja, I., & Tinahones, F. (2016) · Nutrients · doi:10.3390/nu8060320 · Cited by 145
“Our group, in collaboration with other groups, has shown that metabolically healthy subjects have higher lipogenic [39,40] and angiogenic [41,42] capacity than metabolically unhealthy patients.”
BackgroundSelf-citation
Metadata
- Authors
- Clemente-Postigo, M., Queipo-Ortuño, M. I., Fernandez-Garcia, D., Gomez-Huelgas, R., Tinahones, F. J., & Cardona, F.
- Affiliations
- Centro de Investigación Biomédica en Red (ES)
- Corresponding author
- Cardona, Fernando
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-09-22
- Volume
- 6
- Issue
- 9
- Pages
- e24783
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3178563
- OpenAlex
- W2039432238
- Cited by
- 124
- References
- 40
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 3 · 2023: 16 · 2022: 5 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 11 · 2017: 14 · 2016: 12 · 2015: 8 · 2014: 10 · 2013: 11 · 2012: 2
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Repositorio Institucional de la Universidad de Málaga (University of Málaga) (submittedVersion, cc-by-nc-nd)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
- Funders
- Servicio Andaluz de Salud (CB06/03/0018)
- Instituto de Salud Carlos III (PS09/00997, CB06/03/0018, CB06/03)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- adipose tissue gene expression, lipid uptake, lipid processing, subcutaneous adipose tissue, visceral adipose tissue, insulin resistance, type 2 diabetes, lipoprotein lipase, FABP4, acylation stimulating protein, LDL receptor-related protein 1, VLDL receptor, body mass index, morbid obesity
- MeSH terms
- Adult, Complement C3, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Lipoprotein Lipase, Male, Middle Aged, Obesity, Morbid, Gene Expression, Body Mass Index, Reverse Transcriptase Polymerase Chain Reaction, Low Density Lipoprotein Receptor-Related Protein-1, Intercellular Signaling Peptides and Proteins, Subcutaneous Fat, Intra-Abdominal Fat, Lipid Metabolism, Fatty Acid-Binding Proteins, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.